Concepedia

Olivier Lantz

OL

Statistics

Publications

168

Citations

30.2K

H-Index

82

Active since

1985

Affiliations

Inserm(Current)

Institut Curie

Centre National de la Recherche Scientifique

Université Paris Cité

Université Paris Sciences et Lettres

Olivier Lantz is an author at Inserm specializing in immunology, life sciences, and t cell biology.

ORCID

Publications per year

1985–2024

168

Publications

168

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

, , +14

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Bernard Escudier, Thierry Dorval, Nathalie Chaput et al. · Journal of Translational Medicine · 2005 · 1.3K citations · Full text

, , +17

Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

Emmanuel Treiner, Livine Duban, Seiamak Bahram et al. · Nature · 2003 · 1.1K citations

, , +12

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

Olivier Lantz, Albert Bendelac · The Journal of Experimental Medicine · 1994 · 1K citations · Full text

, , +17

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17–secreting T cells

Mathilde Dusséaux, Emmanuel Martin, Nacer Serriari et al. · Blood · 2010 · 1K citations · Full text

, , +15

1–5 of 168